GTC

Ghost Tree Capital Portfolio holdings

AUM $276M
This Quarter Return
+3.83%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$261M
AUM Growth
+$261M
Cap. Flow
-$46.6M
Cap. Flow %
-17.84%
Top 10 Hldgs %
50.42%
Holding
67
New
9
Increased
18
Reduced
11
Closed
21

Top Buys

1
ASND icon
Ascendis Pharma
ASND
$9.42M
2
SRPT icon
Sarepta Therapeutics
SRPT
$9.01M
3
MRUS icon
Merus
MRUS
$8.75M
4
APLS icon
Apellis Pharmaceuticals
APLS
$5.91M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
$5.09M

Top Sells

1
XENE icon
Xenon Pharmaceuticals
XENE
$21.6M
2
IOVA icon
Iovance Biotherapeutics
IOVA
$17.3M
3
ALLK
Allakos
ALLK
$9M
4
GHRS icon
GH Research
GHRS
$7M
5
ALDX icon
Aldeyra Therapeutics
ALDX
$6.15M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MLTX icon
51
MoonLake Immunotherapeutics
MLTX
$3.78B
– –
-500,000
Closed -$4.94M
IWM icon
52
iShares Russell 2000 ETF
IWM
$66.6B
– –
0
– –
IOVA icon
53
Iovance Biotherapeutics
IOVA
$800M
– –
-700,000
Closed -$17.3M
IMVT icon
54
Immunovant
IMVT
$2.91B
– –
0
– –
HRMY icon
55
Harmony Biosciences
HRMY
$2.16B
– –
-75,000
Closed -$2.88M
GYRE icon
56
Gyre Therapeutics
GYRE
$734M
– –
-1,000,000
Closed -$4.11M
FULC icon
57
Fulcrum Therapeutics
FULC
$353M
– –
-50,000
Closed -$1.41M
FATE icon
58
Fate Therapeutics
FATE
$115M
– –
-50,000
Closed -$2.96M
CASI icon
59
CASI Pharmaceuticals
CASI
$36.1M
– –
-650,000
Closed -$774K
BYSI icon
60
BeyondSpring
BYSI
$73.4M
– –
0
– –
BNTX icon
61
BioNTech
BNTX
$24.1B
– –
-2,000
Closed -$546K
BCYC
62
Bicycle Therapeutics
BCYC
$492M
– –
-100,000
Closed -$4.16M
AVIR icon
63
Atea Pharmaceuticals
AVIR
$275M
– –
-150,000
Closed -$5.26M
ALLO icon
64
Allogene Therapeutics
ALLO
$249M
– –
-150,000
Closed -$3.86M
ALLK
65
DELISTED
Allakos
ALLK
– –
-85,000
Closed -$9M
ALEC icon
66
Alector
ALEC
$282M
– –
-80,000
Closed -$1.83M
ALDX icon
67
Aldeyra Therapeutics
ALDX
$351M
– –
-700,000
Closed -$6.15M
1 2
3